Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequate Response”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01888874
What this trial is testing

Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1)

Who this might be right for
Rheumatoid Arthritis
Lakefront Biotherapeutics NV 599
Large-scale testing (Phase 3)Ended earlyNCT04115839
What this trial is testing

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy

Who this might be right for
Psoriatic Arthritis
Gilead Sciences 106
Testing effectiveness (Phase 2)Study completedNCT01457677
What this trial is testing

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Who this might be right for
Major Depressive Disorder
Hoffmann-La Roche 357
Testing effectiveness (Phase 2)Study completedNCT04413617
What this trial is testing

TO ASSESS THE EFFICACY AND SAFETY OF PF-06650833, PF-06651600, AND TOFACITINIB ALONE AND IN COMBINATION IN PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATE

Who this might be right for
Rheumatoid Arthritis
Pfizer 460
Testing effectiveness (Phase 2)Ended earlyNCT04888585
What this trial is testing

Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 473
Post-approval studies (Phase 4)Study completedNCT01481142
What this trial is testing

Adacolumn in Refractory UC Patients Trial

Who this might be right for
Ulcerative Colitis, Active Moderate
Otsuka Pharmaceutical Europe Ltd 100
Testing effectiveness (Phase 2)Study completedNCT00221000
What this trial is testing

Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Mallinckrodt 86
Testing effectiveness (Phase 2)Active Not RecruitingNCT03407144
What this trial is testing

Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)

Who this might be right for
Hodgkin Lymphoma
Merck Sharp & Dohme LLC 340
Post-approval studies (Phase 4)Active Not RecruitingNCT07381465
What this trial is testing

Efficacy and Safety of IL-1 Inhibitors in Mild to Moderate Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
Chinese SLE Treatment And Research Group 15
Post-approval studies (Phase 4)Study completedNCT02547714
What this trial is testing

Open-label Study of Subcutaneous Secukinumab to Evaluate Efficacy and Safety in Patients With Plaque Psoriasis Who Had Inadequate Response to Cyclosporine A

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 34
Testing effectiveness (Phase 2)Study completedNCT03637556
What this trial is testing

Pilot Study to Assess the Safety, PK and Iron Chelating Activity of DST-0509 (Deferasirox) in Thalassemia Patients Refractory to Chelation

Who this might be right for
Thalassemia Major
DisperSol Technologies, LLC 25
Large-scale testing (Phase 3)Study completedNCT03671148
What this trial is testing

A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies)

Who this might be right for
Psoriatic Arthritis (PsA)
AbbVie 444
Large-scale testing (Phase 3)Study completedNCT00960440
What this trial is testing

Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) Inhibitors

Who this might be right for
Arthritis, Rheumatoid
Pfizer 399
Testing effectiveness (Phase 2)Ended earlyNCT00779220
What this trial is testing

Evaluate the Efficacy, Safety and Pharmacokinetics/Pharmacodynamics (PK/PD) of Ocrelizumab in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Chugai Pharmaceutical 152
Large-scale testing (Phase 3)Study completedNCT03830203
What this trial is testing

Comparative Study of BAT1806 to RoActemra® in Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Bio-Thera Solutions 621
Testing effectiveness (Phase 2)Study completedNCT00518154
What this trial is testing

Pilot Study of Pyridostigmine Upon Immune Activation in HIV-1 Patients Who Have an Inadequate Immune Response

Who this might be right for
HIV Infections
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 7
Post-approval studies (Phase 4)Study completedNCT01089023
What this trial is testing

Tocilizumab as Monotherapy or in Combination With DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 95
Large-scale testing (Phase 3)Ended earlyNCT00603525
What this trial is testing

Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to TNF-α Antagonist Therapy

Who this might be right for
Arthritis, Rheumatoid
GlaxoSmithKline 169
Post-approval studies (Phase 4)Study completedNCT00749515
What this trial is testing

Pilot Study for Patients With Poor Response to Deferasirox

Who this might be right for
Transfusion-dependent HemachromatosisThalassemia MajorSickle Cell Disease
Boston Children's Hospital 15
Testing effectiveness (Phase 2)Study completedNCT05279417
What this trial is testing

ATI-450 Plus Methotrexate (MTX) Versus Placebo Plus MTX in Participants With Moderate to Severe Active Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Aclaris Therapeutics, Inc. 251
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation